Literature DB >> 15618269

{alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle.

David G Lambert1, Gail D Thomas.   

Abstract

Vasoconstrictor responses to sympathetic nerve stimulation and their sensitivity to metabolic modulation reportedly differ in fast-twitch and slow-twitch muscles, but the underlying mechanisms are not known. Both alpha(1)- and alpha(2)-adrenoceptors mediate these vascular responses in fast-twitch muscle, while their roles in slow-twitch muscle are less well defined. In this study, the phosphorylation of smooth muscle myosin regulatory light chain (smRLC) was measured as an index of vasoconstriction in slow-twitch soleus muscles and fast-twitch extensor digitorum longus (EDL) muscles isolated from C57BL/6J mice. In soleus muscles, incubation with phenylephrine (PE) or UK 14,304 to selectively activate alpha(1)- or alpha(2)-adrenoceptors resulted in concentration-dependent increases in smRLC phosphorylation. To evaluate metabolic modulation of these responses, vasodilator pathways previously implicated in such modulation in fast-twitch muscle were activated in soleus muscles by treatment with the nitric oxide (NO) donor nitroprusside or the ATP-sensitive potassium (K(ATP)) channel opener cromakalim. Both drugs inhibited responses to UK 14,304, but not to PE. The effect of nitroprusside to antagonize UK 14,304 responses was prevented by inhibition of guanylyl cyclase or by blockade of K(ATP) channels, but not by blockade of other potassium channels. Results were similar in EDL muscles. These data provide the first evidence for alpha(2)-adrenoceptor-mediated constriction in slow-twitch muscle, and show that it is sensitive to modulation by NO via a cGMP-dependent mechanism that requires K(ATP) channel activation. Based on the similar findings in soleus and EDL muscles, fibre type does not appear to determine the innate vascular response to alpha(1)- or alpha(2)-adrenoceptor activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618269      PMCID: PMC1665625          DOI: 10.1113/jphysiol.2004.080705

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

1.  Exercise attenuates alpha-adrenergic-receptor responsiveness in skeletal muscle vasculature.

Authors:  J B Buckwalter; J S Naik; Z Valic; P S Clifford
Journal:  J Appl Physiol (1985)       Date:  2001-01

Review 2.  Vascular adrenoceptors: an update.

Authors:  S Guimarães; D Moura
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.

Authors:  G D Thomas; J Hansen; R G Victor
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.

Authors:  V Sauzeau; H Le Jeune; C Cario-Toumaniantz; A Smolenski; S M Lohmann; J Bertoglio; P Chardin; P Pacaud; G Loirand
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

5.  Cyclic GMP regulates cromakalim-induced relaxation in the rat aortic smooth muscle: role of cyclic GMP in K(ATP)-channels.

Authors:  C C Wu; S J Chen; M H Yen
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

6.  Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.

Authors:  G D Thomas; R G Victor
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

7.  Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors:  K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

8.  Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles.

Authors:  R W Grange; E Isotani; K S Lau; K E Kamm; P L Huang; J T Stull
Journal:  Physiol Genomics       Date:  2001-02-07       Impact factor: 3.107

9.  Inhibition of KATP channel activity augments baroreflex-mediated vasoconstriction in exercising human skeletal muscle.

Authors:  David Melvin Keller; Shigehiko Ogoh; Shane Greene; A Olivencia-Yurvati; Peter B Raven
Journal:  J Physiol       Date:  2004-09-02       Impact factor: 5.182

10.  Inhibition of arteriole alpha 2- but not alpha 1-adrenoceptor constriction by acidosis and hypoxia in vitro.

Authors:  J Tateishi; J E Faber
Journal:  Am J Physiol       Date:  1995-05
View more
  5 in total

1.  Heterogeneous oxygenation in nonexercising triceps surae muscle during contralateral isometric exercise.

Authors:  Masaki Mizuno; Ken Tokizawa; Isao Muraoka
Journal:  Eur J Appl Physiol       Date:  2006-03-25       Impact factor: 3.078

2.  Adrenergic control of vascular resistance varies in muscles composed of different fiber types: influence of the vascular endothelium.

Authors:  Bradley J Behnke; Robert B Armstrong; Michael D Delp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

3.  Regional heterogeneity of α-adrenoreceptor subtypes in arteriolar networks of mouse skeletal muscle.

Authors:  Alex W Moore; William F Jackson; Steven S Segal
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

4.  Exercise hyperemia and vasoconstrictor responses in humans with cystic fibrosis.

Authors:  William G Schrage; Brad W Wilkins; Vicki L Dean; John P Scott; Nancy K Henry; Mark E Wylam; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2005-07-21

5.  Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009.

Authors:  Giovanni Corrao; Paolo Mazzola; Matteo Monzio Compagnoni; Federico Rea; Luca Merlino; Giorgio Annoni; Giuseppe Mancia
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.